Roche India, Cipla launch antibody cocktail to treat Covid-19

BL Internet Desk | Updated on May 24, 2021

Now, Roche India and Cipla have launched the Antibody Cocktail in India. In a joint statement, Cipla and Roche said. This product is priced at ₹59,750 per dose and could be used to treat mild to moderate cases of Covid-19. The maximum retail price for the multi dose pack (that is each pack can treat two patients) is ₹1,19,500, inclusive of all taxes.



Story: PTI Script & voice-over: Gitanjali Diwakar

Published on May 24, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.